Financial Summary (All financials)
| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| Revenues | 29.3 | 23.0 | 24.9 | 27.7 | 29.3 | 31.3 | 31.6 | 28.9 |
| Revenue growth | 27.3% | -7.4% | -10.0% | -5.5% | -6.5% | -0.8% | 9.3% | 86.1% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 29.3 | 23.0 | 24.9 | 27.7 | 29.3 | 31.3 | 31.6 | 28.9 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | 12.1 | 11.8 | 12.8 | 12.6 | 12.3 | 11.6 | 11.5 | |
| Research and development | | | | | | | | 26.6 |
| General and administrative | | | | | | | | 13.1 |
| EBIT | -1.3 | -10.8 | -12.7 | -12.2 | -11.9 | -9.3 | -8.9 | -11.0 |
| EBIT margin | -4.5% | -46.7% | -51.0% | -44.1% | -40.7% | -29.6% | -28.1% | -38.1% |
| Pre-tax income | -1.3 | -10.7 | -12.6 | -12.2 | -11.9 | -9.2 | -8.7 | -10.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -1.3 | -10.7 | -12.6 | -12.2 | -11.9 | -9.2 | -8.7 | -10.7 |
| Net margin | -4.3% | -46.4% | -50.8% | -43.9% | -40.6% | -29.3% | -27.6% | -37.0% |
| |
| Diluted EPS | ($0.03) | ($0.24) | ($0.29) | ($0.29) | ($0.29) | ($0.23) | ($0.22) | ($0.28) |
| Shares outstanding (diluted) | 47.2 | 44.8 | 44.0 | 42.6 | 40.7 | 40.0 | 39.6 | 37.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|